MR spectroscopy (MRS)

OTHER5 trials

Sponsors

University of Michigan, University of Pittsburgh, Eline C. B. Eskes, University of California, San Francisco

Conditions

Asmd, Visceral TypeBrain TraumaGliomaPosterior Fossa Ependymal TumorTraumatic Brain Injury (TBI)

Phase 2

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

RecruitingNCT07226453

University of California, San FranciscoPosterior Fossa Ependymal Tumor

Start: 2026-03-04End: 2030-03-31Target: 30Updated: 2026-04-02

Unknown Phase

Magnetic Resonance (MR) Spectroscopy and Diffusion Tensor Imaging in Determining Brain Injury and Subsequent Clinical Outcome in Patients of Moderate Brain Trauma

WithdrawnNCT00760903

University of MichiganBrain Trauma

Start: 2003-06-30End: 2009-09-30Updated: 2017-01-06

Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury

CompletedNCT02657135

University of PittsburghTraumatic Brain Injury (TBI)

Start: 2014-03-24End: 2018-03-23Updated: 2018-07-23

Magnetic Resonance Spectroscopy in Acid Sphingomyelinase Deficiency

Eline C. B. EskesAsmd, Visceral Type

Start: 2023-05-05End: 2024-09-01Target: 34Updated: 2023-06-15

Assessing Brain Metabolism Using MRS With Deuterated Glucose

Active, not recruitingNCT06594315

University of California, San FranciscoGlioma

Start: 2022-07-20End: 2027-07-31Target: 80Updated: 2025-09-18